Choosing Cancer Weapons With the Best Aim
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
The Insider's Guide To Translational Medicine
Wielding New Cancer Weapons Forged in Cell-Free DNA: A Wake Up Call For The Entire Biotech Industry
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Drowning in Data: A Data Science Primer for a Translational Scientist
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our …
Hunting Cancer Before It Can Hunt You: A Bird's Eye View of Cell-Free DNA Market Trends
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
Predicting a Patient’s Future with a Crystal Ball Comprised of Cell-free DNA
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
Quarterbacking a Patient's Fight Against Cancer
In the incredibly competitive world of drug development, comprehensive precision, and healthtech, every strategic control point is essential. Over the …
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography
We are witnessing a revolution in cancer therapeutics that is truly bewildering. The number of novel drugs with unique mechanisms …
